Heron Therapeutics Inc vs Raymond James Financial, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Raymond James Financial, Inc. trades at $168.25 (market cap $32.80B). The key difference: Raymond James Financial, Inc. is far larger — about 358.6× Heron Therapeutics Inc's market cap, and Raymond James Financial, Inc. pays a 1.28% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | RJF | |
|---|---|---|
Market Cap | $91.46M | $32.80B |
Sector | Health | Financials |
52-Week High | $1.96 | $176.43 |
52-Week Low | $0.39 | $140.89 |
Enterprise Value | $189.36M | — |
Dividend Yield | — | 1.28% |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Raymond James Financial is a financial holding company whose major operations include wealth management, investment banking, asset management, and commercial banking. The company has more than 14,000 employees and supports more than 5,000 independent contractor financial advisors across the United States, Canada, and the United Kingdom. Approximately 90% of the company's revenue is from the U.S. and 70% is from the company's wealth-management segment.
Read more on RJF →